Sign in
4

Changes in Ownership

Cullinan Therapeutics, Inc. Filed Acc 0000899243-22-025971

Acting Chief Business Officer sold 40,000 shares at an average $13.33 ($533,304)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Savill Corrine Acting Chief Business Officer 2022-07-11 Sale −39,800 $13.33 $530,534 169,815 D
Savill Corrine Acting Chief Business Officer 2022-07-11 Sale −200 $13.85 $2,770 169,615 D
Open-market sales · 40,000 sh · avg $13.33 · $533,304
Loading xslF345X03/doc4.xml…